Vitreoretinal Associates, P.A. /ID# 256150

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Macular degeneration

Running trials

• Active, not recruiting

  Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

  NCT04704921· Phase 2/3· AbbVie· Source